Tradename | Company | Number | Date | Products |
---|---|---|---|---|
SULFAMETHOXAZOLE AND TRIMETHOPRIM AND PHENAZOPYRIDINE HYDROCHLORIDE | Able Laboratories | N-021105 DISCN | 2001-06-26 | 1 products |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
SEPTRA | Monarch Pharmaceuticals | N-017376 RX | 1982-01-01 | 1 products |
SEPTRA DS | Monarch Pharmaceuticals | N-017376 RX | 1982-01-01 | 1 products |
SULFATRIM PEDIATRIC | PAI Pharma | N-018615 RX | 1983-01-07 | 1 products |
BACTRIM | Sun Pharmaceutical Industries | N-017377 RX | 1982-01-01 | 1 products, RLD |
BACTRIM DS | Sun Pharmaceutical Industries | N-017377 RX | 1982-01-01 | 1 products, RLD, RS |
Code | Description |
---|---|
S0039 | Injection, sulfamethoxazole and trimethoprim, 10 ml |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hiv infections | D015658 | EFO_0000764 | B20 | 4 | 7 | 16 | 4 | 12 | 41 |
Urinary tract infections | D014552 | EFO_0003103 | N39.0 | 1 | 8 | 5 | 9 | 8 | 30 |
Pneumocystis pneumonia | D011020 | EFO_0007448 | B59 | 2 | 6 | 13 | 4 | 7 | 30 |
Malaria | D008288 | EFO_0001068 | B54 | — | 2 | 10 | 2 | 5 | 19 |
Hiv | D006678 | — | O98.7 | — | 1 | 3 | 3 | 7 | 14 |
Pneumonia | D011014 | EFO_0003106 | — | — | 2 | 5 | 2 | 5 | 12 |
Infections | D007239 | EFO_0000544 | — | 1 | 2 | 2 | 4 | 2 | 10 |
Tuberculosis | D014376 | EFO_0000774 | A15-A19 | — | 3 | 3 | 1 | 2 | 7 |
Methicillin-resistant staphylococcus aureus | D055624 | — | — | — | 2 | 1 | 1 | 2 | 6 |
Diarrhea | D003967 | HP_0002014 | R19.7 | — | — | — | 1 | 3 | 4 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Bacterial infections | D001424 | — | A49 | 5 | 1 | 1 | — | 2 | 9 |
Abscess | D000038 | EFO_0003030 | — | — | — | 2 | — | 6 | 8 |
Sepsis | D018805 | HP_0100806 | A41.9 | — | 1 | 3 | — | 1 | 5 |
Osteomyelitis | D010019 | EFO_0003102 | M86 | 1 | 1 | 1 | — | 1 | 4 |
Multiple myeloma | D009101 | — | C90.0 | — | 3 | 1 | — | — | 4 |
Staphylococcal infections | D013203 | — | A49.01 | — | 2 | 3 | — | — | 4 |
Mycoses | D009181 | — | B35-B49 | 1 | — | 1 | — | — | 2 |
Pneumocystis | D011010 | — | — | — | — | 2 | — | — | 2 |
Idiopathic pulmonary fibrosis | D054990 | — | J84.112 | — | — | 2 | — | — | 2 |
Vesico-ureteral reflux | D014718 | EFO_0007536 | N13.7 | — | — | 2 | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lymphoma | D008223 | — | C85.9 | 1 | 4 | — | — | 1 | 5 |
Leukemia | D007938 | — | C95 | 2 | 2 | — | — | — | 3 |
Cystic fibrosis | D003550 | EFO_0000390 | E84 | — | 3 | — | — | — | 3 |
Sinusitis | D012852 | EFO_0007486 | J32 | — | 1 | — | — | 1 | 2 |
Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | — | 1 | — | — | 1 | 2 |
Chronic kidney failure | D007676 | EFO_0003884 | N18.6 | — | 1 | — | — | 1 | 2 |
Neoplasms | D009369 | — | C80 | 2 | 1 | — | — | — | 2 |
Staphylococcus aureus | D013211 | NCBITaxon_1280 | — | — | 1 | — | — | 1 | 2 |
Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 2 | 1 | — | — | — | 2 |
Plasma cell neoplasms | D054219 | — | — | 1 | 2 | — | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 2 | — | — | — | — | 2 |
Congenital microtia | D065817 | — | Q16.0 | 1 | — | — | — | — | 1 |
Brain neoplasms | D001932 | EFO_0003833 | C71 | 1 | — | — | — | — | 1 |
Glioblastoma | D005909 | EFO_0000515 | — | 1 | — | — | — | — | 1 |
Astrocytoma | D001254 | EFO_0000271 | — | 1 | — | — | — | — | 1 |
Macular degeneration | D008268 | EFO_0001365 | H35.30 | 1 | — | — | — | — | 1 |
Erectile dysfunction | D007172 | EFO_0004234 | F52.21 | 1 | — | — | — | — | 1 |
Short bowel syndrome | D012778 | — | K90.82 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Bronchitis | D001991 | — | J40 | — | — | — | — | 3 | 3 |
Hypospadias | D007021 | EFO_0004209 | Q54 | — | — | — | — | 3 | 3 |
Retinal detachment | D012163 | EFO_0005773 | H33.2 | — | — | — | — | 1 | 1 |
Aortic dissection | D000784 | — | I71.0 | — | — | — | — | 1 | 1 |
Delirium | D003693 | — | R41.0 | — | — | — | — | 1 | 1 |
Whooping cough | D014917 | EFO_0000650 | A37 | — | — | — | — | 1 | 1 |
Respiratory tract infections | D012141 | — | J06.9 | — | — | — | — | 1 | 1 |
Neonatal sepsis | D000071074 | HP_0040187 | — | — | — | — | — | 1 | 1 |
Nephrolithiasis | D053040 | — | N20.0 | — | — | — | — | 1 | 1 |
Ulcerative colitis | D003093 | EFO_0000729 | K51 | — | — | — | — | 1 | 1 |
Drug common name | Sulfamethoxazole |
INN | sulfamethoxazole |
Description | Sulfamethoxazole is an isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position. It has a role as an antibacterial agent, an antiinfective agent, an epitope, an EC 2.5.1.15 (dihydropteroate synthase) inhibitor, an antimicrobial agent, a P450 inhibitor, an EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor, an environmental contaminant, a xenobiotic and a drug allergen. It is a sulfonamide, a member of isoxazoles, a substituted aniline and a sulfonamide antibiotic. It is functionally related to a sulfanilamide. |
Classification | Small molecule |
Drug class | antimicrobials (sulfonamides derivatives) |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1 |
PDB | — |
CAS-ID | 723-46-6 |
RxCUI | — |
ChEMBL ID | CHEMBL443 |
ChEBI ID | 9332 |
PubChem CID | 5329 |
DrugBank | DB01015 |
UNII ID | JE42381TNV (ChemIDplus, GSRS) |